The VHH has been coupled with three different radionuclides: 111In, 225Ac and 131I. Each radionuclide coupled to VHH was tested one by one or in combination and the impact on survival was evaluated and compared to trastuzumab, a conventional antibody targeting HER2 and already approved for HER2-positive cancer treatment. Here, ERBB2 is linked to cancer.